Neurosurgery Clinic Trends 2026: How High and How Often Can You Run the MRI?

Neurosurgery clinics face a two-sided environment: tailwinds on demand, headwinds on cost and capital.

On demand, ageing produces widespread presentations of headache, dizziness, numbness, and memory concerns, and clinic practice combines these common symptoms with MRI and CT imaging. Most independent neurosurgery clinics run a common business model: a headache, dizziness, and memory clinic, plus same-day MRI, plus self-pay brain screening. Freedom from emergency surgery and on-call duty, working daytime hours centered on outpatient care and imaging, is repeatedly cited as the motivation for leaving hospital practice.

1. Macro environment — a positive revision, but net proceeds depend on equipment repayment

The FY2026 revision raised base fees +3.09%, far above the previous +0.88%, comprising +1.70% for wage measures, +0.76% for inflation, +0.09% for food and utilities, and +0.44% for emergency response.

Changes include the outpatient and home first-visit base-up evaluation fee rising from 6 to 17 points, a new inflation response evaluation on first and return visits, the addition of a requirement for blood testing at least once every six months under the lifestyle disease management fee, and consolidation of the dementia community care add-on into the primary care function framework with long-term care benefit recipients added to eligibility. For clinics handling post-stroke lifestyle disease management and dementia follow-up on an outpatient basis, these restructurings bear directly on billing and operations.

Meanwhile, the cost structure of dependence on expensive imaging equipment is unchanged. MRI and CT acquisition, shielding construction, remote reading and maintenance costs, plus wage and price inflation all push up fixed costs — so the positive revision does not translate directly into profit.

2. Characteristics of newly opened clinics — a high-capital model

The defining feature is an MRI-centered, high-initial-investment model. Total opening capital for a neurosurgery clinic with MRI runs roughly ¥100–300 million.

One concrete example in the Kansai region (230 m²) totals about ¥150 million: ¥31 million interior construction, ¥80 million MRI acquisition, ¥3 million deposit, ¥4 million medical association entry fee, ¥2 million opening costs, ¥30 million working capital — financed through ¥120 million in bank borrowing, ¥15 million in leases, and ¥15 million in equity. Another analysis cites ¥50–100 million for MRI, over ¥40 million for interior work including shielding, over ¥30 million in working capital, and a minimum requirement of ¥150 million.

On economics, medical supply costs run 2–5% of revenue — lower than other specialties — producing a low-cost structure with 40–50% margins. Director income in the stable phase is cited at ¥30–80 million or more, with a success case reaching ¥95 million in annual revenue and over ¥40 million in profit in the second year. Others note that repayment burden on expensive equipment means "less tends to remain in hand than in other specialties," so apparent margin and actual net proceeds diverge readily.

Four points are repeatedly emphasized for avoiding failure:

1. Secure at least ¥30 million in working capital
2. Scrutinize the business plan so bank borrowing does not become excessive (over ¥300 million)
3. Raise MRI utilization through inter-clinic referral from neighboring orthopedics, internal medicine, and gynecology practices
4. Secure referred patients through hospital ties (such as continuing weekly hospital sessions)

On location and construction, property selection and interior design accounting for MRI power, weight, magnetic shielding, and delivery access determine success.

In short, "how to run and recover an expensive MRI investment" is the core of the model, and the standard design stacks imaging utilization across three sources: own insured practice, referred imaging from neighboring specialties, and self-pay brain screening.

3. Revenue areas specific to neurosurgery

Outpatient practice built on imaging

Revenue centers on outpatient care that, for common presentations of headache, dizziness, numbness, and memory concerns, images with MRI/MRA and CT on the spot to exclude or identify organic disease — brain tumors, aneurysms, silent infarcts, chronic subdural hematoma.

Neurosurgery is strong in surgical intervention and imaging, with a different scope from neurology, which focuses on medical management of Parkinson's disease and other neurological disorders. At the clinic level this boundary is fluid, and more practices declare both while absorbing medical follow-up — so a neurosurgery practice with MRI is well served by leading with imaging capability as its differentiator.

Post-stroke outpatient follow-up and secondary prevention

After acute treatment for stroke, providing community-based recurrence prevention — antithrombotic and antihypertensive management, lifestyle disease control — is another important role. Many clinics communicate specialized expertise in stroke and dementia prevention anchored in hypertension management. This area connects to both recurring insured revenue through the lifestyle disease management fee and imaging revenue through periodic MRI follow-up.

Implementing AI imaging

Neurosurgery is a leading area for AI imaging implementation. The emblematic case is Fujifilm's cerebral aneurysm detection program (FS-AI697), which received regulatory approval on July 6, 2026.

It supports detection of aneurysms 2 mm or larger from MRA images, presenting analysis results at the same moment the physician reads the image — Japan's first approval of a concurrent-read device. Reader sensitivity is reported to improve by over 10%.

It aligns strongly with the work of finding low-frequency aneurysms across large volumes of screening MRA images, feeding directly into brain screening quality and throughput on both missed-lesion risk and reading efficiency. Some clinics have begun promoting AI imaging adoption as a differentiator.

4. Self-pay services — brain screening as the pillar

The self-pay pillar is unambiguously brain screening. A basic package (head MRI/MRA plus carotid ultrasound, one to two hours) runs roughly ¥15,000–25,000, and a detailed course adding head CT, blood chemistry, ECG, ABI, VSRAD dementia diagnostic support, and simple cognitive testing runs ¥25,000–50,000.

Many municipalities and health insurance societies provide subsidies — Arakawa Ward covers half (up to ¥20,000), Takatsuki City up to 80% (capped at ¥30,000). Subsidies lower out-of-pocket costs and the barrier to screening, but prices tend to cluster at the subsidy ceiling, so clinics design unit price and added value through depth of testing (VSRAD, cognitive assessment, concurrent carotid ultrasound).

Precisely because brain screening is uninsured self-pay, it fills empty MRI slots at high value while routing patients with findings into insured care — making it central to equipment payback strategy.

The other current is the sophistication of headache clinics around anti-CGRP antibodies for migraine prevention. Emgality, Ajovy, and Aimovig are all insured injectables, but even at 30% coinsurance run roughly ¥12,500–13,500 per dose and require self-injection on a regular schedule. Insurance eligibility is limited to patients with at least four migraine days monthly on average whose daily life remains impaired by acute treatment or existing preventives, or who cannot continue them — so this is not strictly self-pay, but specialized headache clinics attract these high-value, continuing-prescription patients, converting them into differentiation and stable recurring revenue.

5. Management implications

Management ultimately converges on how high and how often you can run an expensive MRI, and recover it.

First, maximize MRI utilization. The standard is filling slots from three sources — own outpatients (headache, dizziness, memory), referred imaging from neighboring specialties, and self-pay brain screening — and securing partners from the opening stage determines payback speed.

Second, design the loop between self-pay screening and insured care. Routing patients with findings from screening into outpatient follow-up, additional testing, and post-stroke management, while directing outpatients toward screening, lifts both unit price and recurring revenue.

Third, differentiate in advanced areas. AI imaging for aneurysm detection improving screening quality and efficiency, specialized headache clinics handling CGRP antibodies, and dementia and post-stroke lifestyle disease management are all sources of both patient draw and recurring revenue.

The FY2026 positive revision is a tailwind, but wage and price inflation absorb most of it, so net proceeds depend on managing equipment repayment and personnel costs.

6. How an AI EMR addresses these problems — feature by feature

Neurosurgery economics come down to how much you can run an MRI costing tens of millions of yen. A bottleneck anywhere — documentation, reading, booking — shows up directly as lost machine utilization. Here is how Pottech's AI Karte clears those bottlenecks, feature by feature.

Feature 1: Practice analytics — make MRI utilization the sole payback metric

Visit volume, revenue per patient, and monthly trends are aggregated and visualized automatically, with CSV export.

In a business recovering ¥100–300 million in investment, equipment utilization is the operating metric. How much do the three inflow routes — insured outpatient MRI, referred imaging from other specialties, self-pay screening — fill each day and time band? Where do gaps concentrate? Without that visibility you cannot judge whether to expand screening slots or invest in developing referral partners.

Given a low-cost structure with 40–50% margins but reduced net proceeds from equipment repayment, this specialty needs visibility into gross margin per slot, not headline revenue.

Feature 2: Booking and reception — feed three inflow routes into one machine

In-person and online bookings are managed together, searchable instantly by name, phone number, or card number, with segmented slot management.

A single MRI absorbs three different flows with different durations and entry points: same-day imaging for own outpatients, scheduled examinations referred from other specialties, and screening appointments. If same-day MRI is your acquisition weapon, you need slot design that preserves headroom for walk-ins while protecting screening capacity. Uniform slots do not work.

When accepting referred imaging, slot management by referring practice and results-return tracking also arise.

Feature 3: Integrations and APIs — unify images, AI analysis, and remote reading reports

An OAuth2 gateway, MCP server, and HAPI FHIR enable integration with external systems.

In this specialty, information returns from three external systems: the MRI itself, AI analysis (aneurysm detection), and the remote reading service. Disconnection from the chart produces waiting, transcription, and missed confirmations — making "same-day imaging, same-day explanation" impossible to deliver.

For a clinic without a staff radiologist, combining remote reading with AI analysis to assure reading quality is a prerequisite. Whether that information is integrated into the record determines both care quality and throughput.

Feature 4: Document generation — auto-draft brain screening reports

AI generates medical documents from patient data, with registered templates preserving the clinic's format.

Brain screening returns a report to every participant. Most have no findings, but the report is produced in every case. It is a highly templated document including VSRAD analysis results, carotid ultrasound findings, and cognitive test scores — an area where draft generation pays off readily. The same applies to referral letters for patients with findings and explanations of conversion to insured care.

Feature 5: Charting and orders — lighten highly structured interviews

AI generates SOAP notes from consultation audio, and web and paper questionnaires are digitized by camera.

Headache and dizziness interviews are highly structured yet information-dense: headache character, frequency, accompanying symptoms; dizziness character and triggers; history and medications. Capturing these in structured form through a pre-visit web questionnaire lets the consultation focus on differentiation and explanation. In dementia follow-up, longitudinal recording of cognitive scores also bears on management fee requirements.

Feature 6: Patient PHR app integration ("Pote-kun") — systematize the screening-outpatient loop

Appointment booking, medication reminders, and LINE login with push notifications.

The core of revenue design here is the mutual referral loop: screening finds something and routes into insured outpatient care; outpatients are guided toward screening. But screening is a low-frequency event on a one- to two-year cycle, and relying on patient memory guarantees losses. Notification at the recommended interval is the practical way to actually run the loop.

Because anti-CGRP antibodies involve monthly or four-weekly self-injection, dosing reminders act directly on continuation rates.

Primary sources

• Wemex/Medicom, "Neurosurgery: opening without failure — income and capital explained" https://www.phchd.com/jp/medicom/park/idea/opening-neurosurgery
• Clinic Station, "How much capital does a neurosurgery practice need?" https://clinicstation.jp/column/6525
• CUC Advisory Partners, "Neurosurgery opening capital and income: MRI break-even" https://www.cuc-jpn.com/cucap/24208/
• YA+A Yokomatsu Architects, "Neurosurgery clinic capital and property selection" https://www.yokomatsu.info/blog/2025/11/21/202511-11-neurosurgery-clinic/
• Yuyama, "Key points and countermeasures for the FY2026 revision" https://www.yuyama.co.jp/column/medicalrecord/revision-of-medical-fees-2026-2/
• Ningen Dock no Mikata, "Brain screening costs and subsidies" https://www.mrso.jp/mikata/73/
• Fujifilm news release, "Japan's first regulatory approval of a concurrent-read device supporting cerebral aneurysm detection" https://www.fujifilm.com/jp/ja/news/list/13678
• Nikkei, "Fujifilm develops software supporting aneurysm detection from MRA images" https://www.nikkei.com/article/DGXZRSP710171_S6A720C2000000/